Private Market View

SalioGen Therapeutics

Drug Discovery

Last price · $/share
Implied valuation
Total raised
$132.3M
Last round
Early Stage VC (Series B)
May 2022
Team — not yet on record

No current team members for SalioGen Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·Watchlist + deal alerts for SalioGen Therapeutics
Create free account
No card required